skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

20 Total results for product and free and sample content found

Medtech Insight: 世界の医療機器・医療技術の最新情報

Coronavirus All FDA Inspections Of Chinese Manufacturing Facilities Come To Screeching Halt

By Shawn M. Schmitt 17 Feb 2020

In a late Friday news statement, agency head Stephen Hahn also warned of possible “shortages of critical medical products” The US agency has suspended all routine surveillance inspections in China through the end of March because of coronavirus fears, commissioner Stephen Hahn announced late on 14 February. Despite expecting medical product shortages, Hahn said the agency is being proactive: “We are not waiting for drug and device manufacturers to report shortages to us” before acting. The timing of Hahn’s statement – at 6 p.m. EST on a Friday, at the beginning of a three-day US holiday weekend – suggests he isn’t particularly excited to share the information.

Topic Coronavirus

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Gilead Joins Coronavirus Fray With Repurposed Antiviral

07 Feb 2020

US antiviral specialist Gilead is working to provide its experimental drug remdesivir to treat the China coronavirus, while other potential treatments and alliances continue to emerge, including between Wuhan-based BravoVax and US venture GeoVax.

Topic Coronavirus

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

GSK Joins Race To Tackle Coronavirus

07 Feb 2020

Corona_Virus__Scrip

The pharma major is providing its adjuvant system, designed to enhance the body’s immune response, to help the Coalition for Epidemic Preparedness Innovations' efforts to accelerate the creation of a vaccine for the coronavirus strain that broke out in China and has spread to 24 countries.

Topic Coronavirus

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Novel Virus Brings Novel Threats To Global Pharmaceutical Manufacturing

By Bowman Cox 07 Feb 2020

As coronavirus spreads into China’s manufacturing region, quarantines and travel restrictions challenge international flow of pharmaceuticals, ingredients and personnel.

Topic Coronavirus

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Coronavirus Notebook: China Generic Antiviral Filed For Emergency Approval

By Brian Yang 07 Feb 2020

China is tightening oversight over suspected coronavirus cases, allowing hospitals to quarantine patients upon their first visit as confirmed infections surpass 20,000. Domestic firm Ascletis has meanwhile filed for the emergency approval of its generic version of AbbVie's Norvir (ritonavir) and a novel combo therapy.

Topic Coronavirus

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

FDA Responds To Coronavirus By Getting Out First Emergency-Use Novel Coronavirus Diagnostic

By Sue Darcey 07 Feb 2020

The US agency on 4 February issued its first Emergency Use Authorization of a 2019-novel coronavirus test by enabling emergency use of the Centers for Disease Control and Prevention’s 2019-nCoV Real-Time RT-PCR Diagnostic Panel. The move will allow use of the test at any CDC-qualified lab across the US.

Topic Coronavirus

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Japan Pharma Unconcerned About Virus Impact - For Now

By Ian Haydock 07 Feb 2020

Spreading China outbreak not a point of focus for companies or analysts in quarterly results briefings.

Topic Coronavirus

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Coronavirus Notebook: Regeneron, HHS To Develop Antibody

07 Feb 2020

Wuhan Institute of Pathology files patent over new use of Gilead's remdesivir and Regeneron expands collaboration with HHS to include 2019-nCoV.

Topic Coronavirus

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

China Coronavirus Cases Up Sharply As Pharma Rushes To Aid

By Brian Yang 30 Jan 2020

AbbVie’s HIV therapy Kaletra is now being used by the Chinese government to treat coronavirus-infected patients after a respiratory expert endorsed its use, while other pharma companies from Bayer to Innovent are showering support as China battles its worst virus outbreak since the SARS epidemic 17 years ago.

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。